A predictive nomogram for two-year growth of CT-indeterminate small pulmonary nodules
- PMID: 34677668
- DOI: 10.1007/s00330-021-08343-5
A predictive nomogram for two-year growth of CT-indeterminate small pulmonary nodules
Abstract
Objectives: Lung cancer is the most common cancer and the leading cause of cancer-related death worldwide. The optimal management of computed tomography (CT)-indeterminate pulmonary nodules is important. To optimize individualized follow-up strategies, we developed a radiomics nomogram for predicting 2-year growth in case of indeterminate small pulmonary nodules.
Methods: A total of 215 histopathology-confirmed small pulmonary nodules (21 benign and 194 malignant) in 205 patients with ultra-high-resolution CT (U-HRCT) were divided into growth and nongrowth nodules and were randomly allocated to the primary (n = 151) or validation (n = 64) group. The least absolute shrinkage and selection operator (LASSO) method was used for radiomics feature selection and radiomics signature determination. Multivariable logistic regression analysis was used to develop a radiomics nomogram that integrated the radiomics signature with significant clinical parameters (sex and nodule type). The area under the curve (AUC) was applied to assess the predictive performance of the radiomics nomogram. The net benefit of the radiomics nomogram was assessed using a clinical decision curve.
Results: The radiomics signature and nomogram yielded AUCs of 0.892 (95% confidence interval [CI]: 0.843-0.940) and 0.911 (95% CI: 0.867-0.955), respectively, in the primary group and 0.826 (95% CI: 0.727-0.926) and 0.843 (95% CI: 0.749-0.937), respectively, in the validation group. The clinical usefulness of the nomogram was demonstrated by decision curve analysis.
Conclusions: A radiomics nomogram was developed by integrating the radiomics signature with clinical parameters and was easily used for the individualized prediction of two-year growth in case of CT-indeterminate small pulmonary nodules.
Key points: • A radiomics nomogram was developed for predicting the two-year growth of CT-indeterminate small pulmonary nodules. • The nomogram integrated a CT-based radiomics signature with clinical parameters and was valuable in developing an individualized follow-up strategy for patients with indeterminate small pulmonary nodules.
Keywords: Growth; Nomograms; Pulmonary nodule; Radiomics; Tomography, X-ray computed.
© 2021. European Society of Radiology.
Similar articles
-
Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.Cancer Commun (Lond). 2020 Jan;40(1):16-24. doi: 10.1002/cac2.12002. Epub 2020 Mar 3. Cancer Commun (Lond). 2020. PMID: 32125097 Free PMC article.
-
Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.Eur Radiol. 2020 Jul;30(7):3650-3659. doi: 10.1007/s00330-020-06776-y. Epub 2020 Mar 11. Eur Radiol. 2020. PMID: 32162003 Free PMC article.
-
A clinical-radiomics nomogram for the preoperative prediction of lung metastasis in colorectal cancer patients with indeterminate pulmonary nodules.Eur Radiol. 2019 Jan;29(1):439-449. doi: 10.1007/s00330-018-5539-3. Epub 2018 Jun 12. Eur Radiol. 2019. PMID: 29948074
-
CT-Based Radiomics Predicts the Malignancy of Pulmonary Nodules: A Systematic Review and Meta-Analysis.Acad Radiol. 2023 Dec;30(12):3064-3075. doi: 10.1016/j.acra.2023.05.026. Epub 2023 Jun 27. Acad Radiol. 2023. PMID: 37385850 Review.
-
The classification of benign and malignant lung nodules based on CT radiomics: a systematic review, quality score assessment, and meta-analysis.Acta Radiol. 2023 Dec;64(12):3074-3084. doi: 10.1177/02841851231205737. Epub 2023 Oct 10. Acta Radiol. 2023. PMID: 37817511 Review.
Cited by
-
Self-reported checklists and quality scoring tools in radiomics: a meta-research.Eur Radiol. 2024 Jan 5. doi: 10.1007/s00330-023-10487-5. Online ahead of print. Eur Radiol. 2024. PMID: 38180530
-
Deep learning for malignancy risk estimation of incidental sub-centimeter pulmonary nodules on CT images.Eur Radiol. 2023 Dec 20. doi: 10.1007/s00330-023-10518-1. Online ahead of print. Eur Radiol. 2023. PMID: 38114849
-
Prediction of subsolid pulmonary nodule growth rate using radiomics.BMC Med Imaging. 2023 Nov 7;23(1):177. doi: 10.1186/s12880-023-01143-x. BMC Med Imaging. 2023. PMID: 37936095 Free PMC article.
-
Preoperative predicting invasiveness of lung adenocarcinoma manifesting as ground-glass nodules based on multimodal images of dual-layer spectral detector CT radiomics models.J Cancer Res Clin Oncol. 2023 Nov;149(17):15425-15438. doi: 10.1007/s00432-023-05311-y. Epub 2023 Aug 29. J Cancer Res Clin Oncol. 2023. PMID: 37642725 Clinical Trial.
-
Neural network-based model for evaluating inert nodules and volume doubling time in T1 lung adenocarcinoma: a nested case-control study.Front Oncol. 2023 May 24;13:1037052. doi: 10.3389/fonc.2023.1037052. eCollection 2023. Front Oncol. 2023. PMID: 37293594 Free PMC article.
References
-
- She J, Yang P, Hong QY, Bai CX (2013) Lung cancer in China challenges and interventions. Chest 143:1117–1126 - DOI
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer 68:394–424 - DOI
-
- Gould MK, Tang T, Liu ILA et al (2015) Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med 192:1208–1214 - DOI
-
- Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7–30 - DOI
-
- Gopal M, Abdullah SE, Grady JJ, Goodwin JS (2010) Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials. J Thorac Oncol 5:1233–1239 - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
